Pre-Filled Syringes Market Forecast 2015-2025 : Prospects for Leading Companies in Plastic Pre-Filled Syringes, Pen Injectors & Autoinjectors, and Glass Pre-Filled Syringes

プレフィルドシリンジ(薬剤充填済み注射器)の世界市場:ガラス製プレフィルドシリンジ、プラスチック製プレフィルドシリンジ

◆タイトル:Pre-Filled Syringes Market Forecast 2015-2025 : Prospects for Leading Companies in Plastic Pre-Filled Syringes, Pen Injectors & Autoinjectors, and Glass Pre-Filled Syringes
◆商品コード:VGAIN502205
◆調査・発行会社:visiongain
◆発行日:2015年2月
◆ページ数:250
◆レポート形式:PDF / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single UserGBP1,799 ⇒換算¥269,850見積依頼/購入/質問フォーム
Five UserGBP2,999 ⇒換算¥449,850見積依頼/購入/質問フォーム
Site License(全社内共有可)GBP4,999 ⇒換算¥749,850見積依頼/購入/質問フォーム
※Single UserとDept Licence(Five User)の場合、DRM(デジタル著作権管理)付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はvisiongainの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、プレフィルドシリンジ(薬剤充填済み注射器)の世界市場について調査・分析し、以下の構成でお届けいたします。

・レポートの概要
・イントロダクション
・プレフィルドシリンジ(薬剤充填済み注射器)の世界市場
 (市場規模予測、市場の成長要因・阻害要因など)
・種類別市場分析
・地域別市場分析
・市場環境分析
・専門家の見解
・主要企業分析
・結論

Pre-filled syringes – new study showing you trends, R&D progress, and predicted revenues
Where’s the pre-filled syringes market heading? Visiongain’s brand new report shows you potential revenues to 2025, assessing data, trends, opportunities and prospects there.

Our 250-page report provides 168 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market, submarket, injected drug and national level. You will see financial results, interviews, trends, opportunities, and revenue predictions. Much opportunity remains in this growing medical devices market.

Forecasts from 2015-2025 and other analyses show you commercial prospects
Besides revenue forecasting to 2025, our new study provides you with recent results, growth rates, and market shares. There you find original analyses, with business outlooks and developments. Discover qualitative analyses (including SWOT and STEP analysis), company profiles and commercial developments. Read the full transcripts of three exclusive expert opinion interviews from industry specialists informing your understanding and allowing you to assess prospects for investments and sales, including:
- Gerresheimer AG
- Richard Harrison, Business Development Manager, Injectables, Bespak Europe
- An interview with an anonymous expert from a leading pre-filled syringes manufacturer

Discover sales predictions for the world market and submarkets
Along with revenue and volume prediction for the overall world market, you see revenue and volume forecasts to 2025 for the following submarkets:
• Glass pre-filled syringes
• Plastic pre-filled syringes
• Pen injectors and autoinjectors.

The report also provides revenue forecasts for the following therapeutic areas of the world pharma market:
• Insulin therapies
• Rheumatoid arthritis therapies
• Multiple sclerosis therapies
• Growth hormones
• Heparins
• Vaccines
• PCSK9 inhibitors.

Our investigation discusses what stimulates and restrains business. You find dynamics of the industry and assess its potential sales, seeing agents likely to achieve the most success.

See revenue forecasts for products
How will leading pre-filled injectable drugs perform to 2025 at world level? Our study forecasts sales of 11 products, including these brands:
• Lantus
• NovoRapid/NovoLog
• Humalog
• Humira
• Enbrel
• Avonex
• Rebif
• Copaxone
• Norditropin
• Genotropin
• Lovenox.

Discover how high revenues can go. You see what’s happening, understanding trends, challenges and opportunities.

Our analysis also breaks the main world forecast into geographical markets.

What are the prospects in the leading regions and countries?
In addition to analyses of the overall world market, you discover individual revenue forecasts for 12 national markets to 2025:
• US
• Japan
• China
• Germany
• France
• UK
• Italy
• Spain
• India
• Brazil
• Russia
• Mexico
• Rest of the World

The report also provides revenue forecasts by regional market to 2025:
• US
• Japan
• EU5
• BRIC
• Rest of the World.

There will be growth in established pharma markets and in developing countries. Our analyses show that India, China, Brazil and Mexico, in particular, will continue to achieve high revenue growth to 2025. Developments worldwide in injectable drug launches and device innovation will influence the market.

Leading companies and potential for market growth
Overall world revenue for pre-filled syringes will reach $4.3bn in 2015, our work forecasts. We predict steady revenue growth from through to 2025. Increasing demand for chronic disease treatment, market entry of biologics and biosimilars and innovative pre-filled injection devices will increase sales to 2025.

Our work shows you what organisations hold greatest potential. See profiles of 7 leading companies, including these:
• BD
• Gerresheimer
• Schott
• SHL Group
• Ypsomed
• Datwyler
• West Pharmaceutical Services.

【レポートの目次】

1. Report Overview
1. Report Overview
1.1 Global Pre-Filled Syringes Market Overview
1.2 Global Pre-Filled Syringes Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2. Introduction to Pre-Filled Syringes
2.1 What are Pre-Filled Syringes?
2.1.1 A Brief History of Pre-Filled Syringes
2.2 Design and Manufacture of Pre-Filled Syringes
2.2.1 Glass and Plastic Syringes
2.2.2 Safety and the Pre-Filled Syringe Market
2.2.3 Concerns over Needlestick Injuries
2.3 An Introduction to Pen Injectors and Autoinjectors
2.3.1 Pen Injectors and Autoinjectors Offer Advantages in Self-Administration
2.3.2 What Determines Injection Device Choice?
2.4 Glass versus Plastic
2.4.1 Glass
2.4.2 Plastic
2.5 Future Directions for Pre-Filled Syringes
2.6 Pre-Filled Syringes: Market Segmentation
2.7 Scope of this Report
2.7.1 Products Excluded from this Report
2.8 Currency Exchange Rates in This Report

3. Pre-Filled Syringes: World Market 2015-2025
3.1 Pre-Filled Syringes as a Share of the Global Drug Delivery Market
3.2 The World Pre-Filled Syringes Market in 2013 and 2014
3.2.1 World Pre-Filled Syringes Market: Market Shares by Segment 2013
3.2.2 Leading Companies in the Pre-Filled Syringes Market
3.3 World Pre-Filled Syringes Market: Sales Forecast by Value, 2015-2025
3.4 World Pre-Filled Syringes Market: Sales Forecast by Volume, 2015-2025
3.5 How Will Segmental Market Shares Change to 2025?
3.6 World Pre-Filled Syringes Market: Drivers and Restraints 2015-2025
3.6.1 Biologics and Biosimilars to Drive Market Growth
3.6.2 Human Factors and Regulatory Requirements
3.6.3 Advances in Pre-Filled Syringe Manufacturing
3.6.4 Market Genericisation and Pre-Filled Syringes
3.6.5 The Injectable Drug Pipeline is Substantial
3.6.6 Competing Drug Delivery Technologies
3.7 Glass Pre-Filled Syringes Lead the Pre-Filled Syringes Market
3.7.1 Glass Pre-Filled Syringes Market: Sales Forecast by Value, 2015-2025
3.7.2 Glass Pre-Filled Syringes Market: Sales Forecast by Volume, 2015-2025
3.7.3 Glass Pre-Filled Syringes: Drivers and Restraints 2015-2025
3.8 Plastic Pre-Filled Syringes: Rapid Growth Forecasted
3.8.1 Plastic Pre-Filled Syringes Market: Sales Forecast by Value, 2015-2025
3.8.2 Plastic Pre-Filled Syringes Market: Sales Forecast by Volume, 2015-2025
3.8.3 Plastic Pre-Filled Syringes: Drivers and Restraints 2015-2025
3.9 Pen Injectors and Autoinjectors: A Growing Segment
3.9.1 Pen Injectors and Autoinjectors Market: Sales Forecast by Value, 2015-2025
3.9.2 Pen Injectors and Autoinjectors Market: Sales Forecast by Volume, 2015-2025
3.9.3 Pen Injectors and Autoinjectors: Drivers and Restraints 2015-2025
3.9.4 Insulin and Other Biologics to Lead Market Growth

4. Leading National and Regional Markets 2015-2025
4.1 National Breakdown of the World Pre-Filled Syringes Market
4.2 World Pre-Filled Syringes Market: National Markets Forecast 2015-2025
4.2.1 How Will National Market Shares Change to 2025?
4.3 Regional Breakdown of the World Pre-Filled Syringes Market
4.4 World Pre-Filled Syringes Market: Regional Markets Forecast 2015-2025
4.4.1 How Will Regional Market Shares Change to 2025?
4.5 US Pre-Filled Syringes Market Forecast 2015-2025
4.5.1 US Pre-Filled Syringes Market: Trends and Developments
4.5.1.1 New Drug and Device Launches to Drive Growth to 2025
4.5.1.2 The Budget Control Act 2011 and the Medical Excise Tax
4.6 Japanese Pre-Filled Syringes Market Forecast 2015-2025
4.7 EU5 Pre-Filled Syringes Market Forecast 2015-2025
4.8 Emerging Markets: Pre-Filled Syringes Market Forecast 2015-2025
4.8.1 Pre-Filled Syringe Manufacturers Are Investing in Emerging Markets
4.8.2 Chinese Pre-Filled Syringes Market Forecast 2015-2025
4.8.2.1 China’s Five Year Plans Prioritise Biotechnology
4.8.3 Indian Pre-Filled Syringes Market Forecast 2015-2025
4.8.4 Russian Pre-Filled Syringes Market Forecast 2015-2025
4.8.5 Brazilian Pre-Filled Syringes Market Forecast 2015-2025
4.8.6 Mexican Pre-Filled Syringes Market Forecast 2015-2025

5. Leading Therapeutic Sectors for Pre-Filled Syringes 2015-2025
5.1 Leading Therapeutic Sectors for Pre-Filled Syringes and Other Injection Devices in 2014
5.1.1 Vaccines and Heparins Are Major Market Sectors
5.1.2 Rising Demand in Chronic Conditions: Autoimmune Diseases and Diabetes
5.1.3 Growth for Key Market Sectors 2015-2025
5.2 Pre-Filled Syringes and Pen Injectors for Diabetes 2015-2025
5.2.1 Insulin Market Forecast 2015-2025
5.2.2 High Rates of Pen Injector Use in the EU and Japan
5.2.3 Insulin Pumps: A Technology to Challenge Pen Injectors to 2025?
5.2.4 MannKind’s Afrezza: Inhalable Insulin Approved in US
5.2.5 Biosimilar Insulin to Reach the Market in 2015?
5.2.5.1 Injection Devices for Biosimilar Insulin Products
5.3 Rheumatoid Arthritis: Leading Biologics Dominate the Market
5.3.1 Rheumatoid Arthritis Market Forecast 2015-2025
5.3.2 All Major Injectable Therapies Are Marketed in Proprietary Devices
5.3.3 Novel Injection Systems for RA: Meeting the Needs of Patients
5.3.4 The Receding Threat from Oral Therapies to 2025
5.4 Self-Injection for Multiple Sclerosis: Outlook 2015-2025
5.4.1 Multiple Sclerosis Market Forecast 2015-2025
5.4.2 All Interferon Betas Available in Autoinjectors from 2014
5.4.3 Oral Therapies to Drive MS Market Growth in this Decade
5.5 Growth Hormones: Outlook to 2025
5.5.1 Growth Hormones Market Forecast 2015-2025
5.5.2 Biosimilar Growth Hormones and Pen Injectors
5.5.3 Uptake of Needle-Free Injectors for Growth Hormones
5.6 Pre-Filled Heparin Syringes 2015-2025
5.6.1 One Brand Led the Heparin Market in 2014
5.6.2 Pre-Filled Syringes for LMWHs
5.6.3 Heparin Market Forecast 2015-2025
5.6.4 Follow-On Heparins: Biosimilars or Generics?
5.7 The Vaccine Market Outlook 2015-2025
5.7.1 Vaccine Market Forecast 2015-2025
5.7.2 Single-Use Devices for Vaccine Delivery
5.7.2.1 BD Uniject: A Private-Public Collaboration
5.7.3 Needle-Free Injectors for Vaccines
5.7.4 Other Trends in Vaccine Delivery
5.8 PCSK9 Inhibitors: The Next Advance in Cholesterol-Lowering Drugs
5.8.1 PCSK9 Inhibitors Market Forecast 2015-2025
5.8.2 PCSK9 Inhibitors and Pre-Filled Syringes/Injectors

6. Leading Pre-Filled Device Therapies 2015-2025
6.1 Leading Insulin Therapies Using Pen Injectors 2015-2025
6.1.1 Lantus: The World’s Best-Selling Insulin Analogue
6.1.1.1 SoloSTAR, ClikSTAR and AllSTAR: Three Pen Injectors for Lantus
6.1.1.2 Lantus: Sales Forecast 2015-2025
6.1.2 NovoLog: The Leading Fast-Acting Insulin
6.1.2.1 NovoLog FlexPen: To Be Retired
6.1.2.2 Novo’s New FlexTouch Pen Launched
6.1.2.3 NovoLog: Sales Forecast 2015-2025
6.1.3 Humalog
6.1.3.1 Humalog: HumaPen and KwikPen
6.1.3.2 Humalog: Sales Forecast 2015-2025
6.2 Top Biologics for Rheumatoid Arthritis: Device Outlook to 2025
6.2.1 Humira: The Biggest-Selling Drug in 2013
6.2.1.1 The Humira Pen Is an Innovative Delivery Device
6.2.1.2 Humira: Sales Forecast 2015-2025
6.2.2 Enbrel: The Leading Competitor to Humira
6.2.2.1 Pre-Filled Injection Devices Available for Enbrel in 2014
6.2.2.2 Enbrel: Sales Forecast 2015-2025
6.3 Multiple Sclerosis: Leading Injectable Therapies 2015-2025
6.3.1. Copaxone: An Injectable Non-Interferon Therapy
6.3.1.1 Copaxone Uses Owen Mumford’s Autoject 2 Autoinjector
6.3.1.2 Next-Generation Copaxone and Generics Expected in 2015
6.3.1.3 Copaxone: Sales Forecast 2015-2025
6.3.2 Avonex
6.3.2.1 Biogen Idec Launched the Avonex Pen in 2011
6.3.2.2 Avonex: Sales Forecast 2015-2025
6.3.3 Rebif
6.3.3.1 Rebif Self-Injection Options: Rebiject II, RebiSmart and RebiDose
6.3.3.2 Rebif: A Similar Outlook to Avonex to 2025?
6.4 Growth Hormones: Two Products Dominated the Market in 2014
6.4.1 Norditropin: the Leading Growth Hormone
6.4.1.1 Norditropin: Sales Forecast 2015-2025
6.4.2 Genotropin: Sales Forecast 2015-2025
6.5 Outlook for Leading Heparin Products 2015-2025
6.5.1 Lovenox: Generic Competition in the US Since 2010
6.5.1.1 Lovenox: Sales Forecast 2015-2025
6.5.2 Fragmin Faces Rivalry from Generic Competition to Lovenox
6.5.2.1 Fragmin: Sales Forecast 2015-2025
6.5.3 Arixtra: Aspen and Mylan Hold Marketing Rights
6.5.3.1 Arixtra: Sales Forecast 2015-2025

7. Leading Pre-Filled Syringe and Related Technology Manufacturers, 2015
7.1 Leading Pre-Filled Syringe Manufacturers in 2014
7.1.1 BD: The Market Leader
7.1.1.1 BD: Pre-Filled Syringes Product Portfolio
7.1.1.2 BD: Market Outlook 2015-2025
7.1.1.3 Recent Acquisitions by BD
7.1.1.4 BD Merging with CareFusion
7.1.1.5 BD AutoShield Duo Pen Needle Launched in 2014
7.1.2 Gerresheimer
7.1.2.1 Gerresheimer: Pre-Filled Syringes Product Portfolio
7.1.2.2 Gerresheimer: Market Outlook 2015-2025
7.1.2.3 Gerresheimer: Products in Development
7.1.2.4 Patent Application for Gerresheimer’s Gx G-Fix Adapter
7.1.2.5 Gerresheimer Commissioned to Manufacture Simponi Autoinjectors?
7.1.2.6 Gerresheimer Opens First Development Center in China
7.1.3 Schott
7.1.3.1 Schott: Pre-Filled Syringes Product Portfolio
7.1.3.2 Schott: Market Outlook 2015-2025
7.1.3.3 Schott: Expansion in India
7.2 Other Notable Pre-Filled Syringe Manufacturers
7.2.1 Baxter: Providing Contract Manufacturing with Pre-Filled Syringes
7.2.2 Nipro: Leading Japanese Contract Manufacturer
7.2.2.1 Nipro’s 2012 Acquisition of MGlas
7.2.3 Stevanato Group/Ompi: Insulin Vials Market Leader
7.2.3.1 Ompi’s Ambitious Geographical Expansion Planned to 2016
7.2.4 Weigao: Pre-Filled Syringes for China and Beyond
7.2.5 Unilife: Pre-Filled Safety Syringes
7.2.6 Roselabs: Entered the Market in 2012
7.2.7 Vetter Pharma: Offering Lyo-Ject Dual-Chamber Syringes
7.2.8 Other Companies
7.3 Leading Pen Injector and Autoinjector Manufacturers in 2014
7.3.1 SHL Group
7.3.1.1 SHL Group: Pen Injectors and Autoinjectors Product Portfolio
7.3.1.2 SHL Group: Market Outlook 2015-2025
7.3.2 Ypsomed
7.3.2.1 Ypsomed: Pen Injectors and Autoinjectors Product Portfolio
7.3.2.2 Ypsomed: Market Outlook 2015-2025
7.3.2.3 Ypsomed: Recent Developments
7.3.3 Haselmeier
7.3.3.1 Haselmeier: Pen Injectors and Autoinjectors Product Portfolio
7.3.3.2 Haselmeier: Market Outlook 2015-2025
7.3.4 Owen Mumford
7.3.4.1 Owen Mumford: Pen Injectors and Autoinjectors Product Portfolio
7.3.4.2 Owen Mumford: Market Outlook 2015-2025
7.3.5 Bespak: Entering the Auto-Injectors Market
7.3.6 Other Leading and Emerging Autoinjector Manufacturers
7.4 Leading Pre-Filled Syringe Component Manufacturers in 2014
7.4.1 Datwyler
7.4.1.1 Datwyler: Market Outlook 2015-2025
7.4.2 West Pharmaceutical Services
7.4.2.1 West Pharmaceutical Services: Market Outlook 2015-2025

8. Qualitative Analysis of the Pre-Filled Syringes Market 2015-2025
8.1 SWOT Analysis of the Pre-Filled Syringes Market
8.2 Strengths
8.2.1 Pre-Filled Syringes and Pen/Autoinjectors Are Used In Chronic Conditions
8.2.2 Device Manufacturers Offer a Range Of Products
8.2.3 Customisation and Product Differentiation
8.2.4 Effective Lifecycle Management
8.3 Weaknesses
8.3.1 Patients with Needle Phobia
8.3.2 Chronic Diseases May Make Pre-Filled Syringes Difficult to Use
8.3.3 Risk of Extractables and Leachables
8.3.4 Higher Cost and Greater Cold Chain and Storage Requirements
8.4 Opportunities
8.4.1 Biosimilars Represent a Growing Market
8.4.2 Viscous and Large-Volume Drugs Require Novel Devices
8.4.3 Technological Developments Expanding Product Portfolios
8.4.4 Many Injectable Drugs in the Pipeline
8.4.5 Growth in Emerging Markets
8.5 Threats
8.5.1 Alternative Technologies: Needle-Free and Bolus Injectors
8.5.2 New Oral Therapies for Many Chronic Conditions
8.5.3 Increasing Regulatory Barriers
8.5.4 Cost Pressures on Healthcare Payers
8.6 STEP Analysis of the Pre-Filled Syringes Market
8.6.1 Social Factors: Rising Disease Incidence and Demand for At-Home Care
8.6.2 Technological Developments: Improved Safety and Administration
8.6.3 Economic Pressures: Pre-Filled Syringes Are Cost Efficient
8.6.3.1 High Barriers to Market Entry Exist
8.6.4 Political Issues: Regulatory Developments for Pre-Filled Syringes
8.7 Regulatory and Safety Outlook for Pre-Filled Syringes, 2015-2025
8.7.1 Needlestick Safety and Prevention
8.7.2 International Regulations for Needlestick Prevention
8.7.2.1 The US: The First Country to Introduce Needlestick Legislation
8.7.2.2 The EU: New Rules from 2013 Onwards
8.7.2.3 Needlestick Safety in Japan 2015-2025
8.7.2.4 Legislation for Needlestick Safety in Emerging Markets
8.7.3 Manufacturers Will Continue to Develop New Devices for Needlestick Prevention
8.7.3.1 Ancillary versus Integrated Safety Devices
8.7.4 Extractables and Leachables
8.7.4.1 Companies Will Reduce Sources of Extractables and Leachables
8.7.4.2 Products that Minimise Extractables and Leachables
8.7.4.3 Protein Aggregation: The Challenge of Biological Drugs
8.7.4.4 Regulatory Requirements for Extractables and Leachables, 2015
8.8 Biologics and the Pre-Filled Syringes Market, 2015-2025
8.8.1 Manufacturing Pre-Filled Syringes for Biologics: Glass versus Plastic
8.8.2 Biologics Provide New Challenges for Device Manufacturers
8.8.2.1 Lyophilised Drugs and Dual-Chamber Devices
8.8.3 Delivery Opportunities for High Viscosity Drugs
8.8.4 Are Biosimilars an Opportunity for Pre-Filled Syringe Manufacturers?
8.9 The Role of Patients in Pre-Filled Syringe Industry Development and Growth
8.9.1 Chronic Disease Incidence 2015-2025
8.9.2 The Rise in At-Home Care
8.9.3 Improving Patient Adherence
8.9.4 Injection Devices Must be Developed for Patient Convenience: Human Factors Engineering
8.10 Technological Developments in Pre-Filled Syringes to 2025
8.10.1 Product Differentiation Will be Vital in Crowded Treatment Markets
8.10.2 Product Customisation: Adapting Injection Devices
8.10.3 Trends in Manufacturing Materials for Pre-Filled Syringes
8.10.4 Competing Technologies Will Challenge Pre-Filled Syringes
8.10.4.1 Will Needle-Free Devices Become a Significant Competing Technology?
8.10.4.2 Patients Prefer Oral Drug Delivery
8.11 Outsourcing in the Pre-Filled Syringe Industry
8.11.1 Contract Medical Device Manufacturing
8.11.2 Contract Filling of Pre-Filled Syringes

9. Research Interviews
9.1 Interview with an Anonymous Expert from a Leading Pre-Filled Syringes Manufacturer
9.1.1 Products and Services Provided
9.1.2 Opportunities in Pre-Filled Syringes
9.1.3 Prominent Therapeutic Areas in 2015-2025
9.1.4 Trends and Developments in Pre-Filled Syringes
9.1.5 Challenges and Future Outlook
9.2 Interview with Gerresheimer AG, Düsseldorf, Germany
9.2.1 Gerresheimer’s Products and Services
9.2.2 Gerresheimer’s Development Center in China for Device Contract Manufacturing
9.2.3 Trends and Developments in Pre-Filled Syringes and Injectors
9.2.4 Will Consulting Become More Important?
9.2.5 Challenges for Manufacturers
9.2.6 The Outlook for Pre-Filled Syringes and Pen/Autoinjectors through 2015-2025
9.3 Interview with Richard Harrison, Business Development Manager, Injectables, Bespak Europe
9.3.1 Bespak
9.3.2 Unmet Needs and Future Directions for Autoinjectors
9.3.3 Challenges in Developing Autoinjectors
9.3.4 Trends from Drug Development Impacting Device Manufacturers

10. Conclusions
10.1 Pre-Filled Syringes and Pen/Autoinjectors: Strong Growth Expected
10.2 The World Pre-Filled Syringes Market in 2014
10.2.1 Current Leading Pre-Filled Syringes Segments
10.2.2 Leading Pre-Filled Syringes Companies
10.2.3 Leading National and Regional Markets
10.3 World Pre-Filled Syringes Market Forecast 2015-2025
10.4 The Future of the Pre-Filled Syringes Market?
10.4.1 Glass Syringes Will Continue to Dominate
10.4.2 Innovation for Growth

11. Glossary

List of Tables
Table 1.1 Leading National Pre-Filled Syringes Market Forecast 2015 ($m, AGR%)
Table 2.1 Currency Exchange Rates, 2013 and 2014
Table 3.1 World Pre-Filled Syringes Market: Revenue ($m) and Units (m), 2013-2014
Table 3.2 World Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), CAGR (%) by Segment, 2014-2025
Table 3.3 World Pre-Filled Syringes Market Forecast: Volume (m units), AGR (%), CAGR (%) by Segment, 2014-2025
Table 3.4 Market Shares (%) of Leading Pre-Filled Syringes Market Segments, by Revenue, 2014, 2019 and 2025
Table 3.5 Market Shares (%) of Leading Pre-Filled Syringes Market Segments, by Volume, 2014, 2019 and 2025
Table 3.6 Glass Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 3.7 Glass Pre-Filled Syringes Market Forecast: Volume (m units), AGR (%), CAGR (%), 2014-2025
Table 3.8 Selected Proprietary Polymers for Plastic Pre-Filled Syringes, 2015
Table 3.9 Plastic Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 3.10 Plastic Pre-Filled Syringes Market Forecast: Volume (m units), AGR (%), CAGR (%), 2014-2025
Table 3.11 Pen Injectors and Autoinjectors Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 3.12 Pen Injectors and Autoinjectors Market Forecast: Volume (m units), AGR (%), CAGR (%), 2014-2025
Table 4.1 World Pre-Filled Syringes Market: Revenues ($m) and Market Shares (%) by National Market, 2014
Table 4.2 World Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), CAGR (%) by National Market, 2014-2025
Table 4.3 Market Shares (%) of Leading National Pre-Filled Syringes Markets, 2014, 2019 and 2025
Table 4.4 World Pre-Filled Syringes Market: Revenues ($m) and Market Shares (%) by Regional Market, 2014
Table 4.5 World Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), CAGR (%) by Regional Market, 2014-2025
Table 4.6 Market Shares (%) of Leading Regional Pre-Filled Syringes Markets, 2014, 2019 and 2025
Table 4.7 US Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 4.8 Japanese Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 4.9 EU5 Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), CAGR (%) by National Market, 2014-2025
Table 4.10 Chinese Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 4.11 Indian Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 4.12 Russian Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 4.13 Brazilian Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 4.14 Mexican Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 5.1 Pen Manufacturing Agreements for Leading Insulin Brand Manufacturers, 2014
Table 5.2 Selected Biosimilar Insulin Pen Injectors, 2015
Table 5.3 Insulin Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 5.4 Rheumatoid Arthritis Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 5.5 Interferon Beta Therapies for Multiple Sclerosis, 2015
Table 5.6 Oral Therapies Launched for Multiple Sclerosis, 2010-2014
Table 5.7 Multiple Sclerosis Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 5.8 Growth Hormone Therapies in Pen Injectors, 2015
Table 5.9 Growth Hormones Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 5.10 Selected Biosimilar Growth Hormones in Emerging Markets, 2014
Table 5.11 Heparins Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 5.12 Vaccines Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 5.13 PCSK9 Inhibitors Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 6.1 Leading Pre-Filled Insulin Therapies: Revenues ($m), AGR (%), CAGR (%), 2009-2013
Table 6.2 Sanofi: Lantus Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 6.3 Novo Nordisk: NovoLog Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 6.4 Eli Lilly: Humalog Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 6.5 Leading Pre-Filled Rheumatoid Arthritis Therapies: Revenues ($m), AGR (%), CAGR (%), 2009-2013
Table 6.6 AbbVie/Eisai: Humira Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 6.7 Amgen/Pfizer: Enbrel Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 6.8 Leading Pre-Filled Multiple Sclerosis Therapies: Revenues ($m), AGR (%), CAGR (%), 2009-2013
Table 6.9 Teva: Copaxone Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 6.10 Biogen Idec: Avonex Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 6.11 Merck Serono: Rebif Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 6.12 Leading Pre-Filled Growth Hormone Therapies: Revenues ($m), AGR (%), CAGR (%), 2009-2013
Table 6.13 Novo Nordisk: Norditropin Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 6.14 Pfizer: Genotropin Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 6.15 Leading Pre-Filled Heparins: Revenues ($m), AGR (%), CAGR (%), 2009-2013
Table 6.16 Sanofi: Lovenox Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 6.17 Pfizer/Eisai: Fragmin Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 6.18 Aspen/Mylan: Arixtra Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 7.1 BD: Overview, 2015
Table 7.2 BD: Pre-Filled Injection Systems, 2015
Table 7.3 BD: Pharmaceutical Systems Revenue ($m), AGR (%), CAGR (%), 2009-2014
Table 7.4 Gerresheimer: Overview, 2015
Table 7.5 Gerresheimer: Plastic Systems and Tubular Glass Revenue ($m), AGR (%), CAGR (%), 2009-2013
Table 7.6 Schott: Overview, 2015
Table 7.7 Schott: Net Revenue ($m), AGR (%), CAGR (%), 2009-2014
Table 7.8 Weigao: Pre-Filled Syringes Revenue ($m) and Production Volume (m units), AGR (%), CAGR (%), 2009-2014
Table 7.9 Unilife: Pre-Filled Syringe Product Portfolio, 2015
Table 7.10 Unilife: Net Revenue ($m), AGR (%), CAGR (%), 2009-2014
Table 7.11 SHL Group: Overview, 2015
Table 7.12 SHL Group: Pen Injector and Autoinjector Portfolio, 2015
Table 7.13 Ypsomed: Overview, 2015
Table 7.14 Ypsomed: Pen Injector and Autoinjector Portfolio, 2015
Table 7.15 Ypsomed: Delivery Devices Revenue ($m), AGR (%), CAGR (%), 2009-2014
Table 7.16 Haselmeier: Overview, 2015
Table 7.17 Haselmeier: Pen Injector and Autoinjector Portfolio, 2015
Table 7.18 Owen Mumford: Overview, 2015
Table 7.19 Owen Mumford: Pen Injector and Autoinjector Portfolio, 2015
Table 7.20 Owen Mumford: Net Revenue ($m), AGR (%), CAGR (%), 2009-2014
Table 7.21 Datwyler: Overview, 2015
Table 7.22 Datwyler: Pharma Packaging Revenue ($m), AGR (%), CAGR (%), 2009-2014
Table 7.23 West Pharmaceutical Services: Overview, 2015
Table 7.24 West Pharmaceutical Services: Packaging Systems and Delivery Systems Revenue ($m), AGR (%), CAGR (%), 2009-2014
Table 8.1 Benefits and Weaknesses to Pre-Filled Syringes as an Injectable Delivery Device, 2015
Table 8.2 Pre-Filled Syringes Market: STEP Analysis, 2015-2025
Table 8.3 Selected Safety Products for Pre-Filled Syringes, 2015
Table 8.4 Selected Pre-Filled Injection Devices for Lyophilised Drugs, 2015
Table 8.5 Leading Blockbuster Biologic Patent Expiries in the US and EU, 2013-2028
Table 8.6 Pre-Filled Syringe Manufacturers: Alternative Injectable Technologies, 2016
Table 8.7 Selected Insulin Pumps Available, 2015
Table 8.8 Oral Drug Competitors for Leading Pre-Filled Syringe Therapeutic Sectors, 2015-2025
Table 8.9 Selected Leading CMOs: Pre-Filled Syringe Filling Capabilities, 2015
Table 9.1 Bespak: Needle-Free Injectors, 2014

List of Figures
Figure 1.1 World 65+ Population Forecast: Size (m), AGR (%), 2014-2025
Figure 1.2 Global Pre-Filled Syringes Market Segmentation Overview, 2015
Figure 2.1 Diagram of Syringe Parts, 2015
Figure 2.2 Timeline of Pre-Filled Syringe Development, 1950-2014
Figure 2.3 Major Trends for Pre-Filled Syringe Market Growth, 2015
Figure 3.1 World Pre-Filled Syringes Market: Revenue ($m) and Units (m), 2013-2014
Figure 3.2 World Pre-Filled Syringes Market by Value: Market Shares (%) by Segment, 2013
Figure 3.3 World Pre-Filled Syringes Market by Volume: Market Shares (%) by Segment, 2013
Figure 3.4 World Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 3.5 World Pre-Filled Syringes Market Forecast: Volume (m units), AGR (%), 2014-2025
Figure 3.6 World Pre-Filled Syringes Market by Value: Market Shares (%) by Segment, 2014
Figure 3.7 World Pre-Filled Syringes Market by Value: Market Shares (%) by Segment, 2019
Figure 3.8 World Pre-Filled Syringes Market by Value: Market Shares (%) by Segment, 2025
Figure 3.9 World Pre-Filled Syringes Market by Volume: Market Shares (%) by Segment, 2014
Figure 3.10 World Pre-Filled Syringes Market by Volume: Market Shares (%) by Segment, 2019
Figure 3.11 World Pre-Filled Syringes Market by Volume: Market Shares (%) by Segment, 2025
Figure 3.12 World Pre-Filled Syringes Market: Drivers and Restraints, 2015-2025
Figure 3.13 Glass Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 3.14 Glass Pre-Filled Syringes Market Forecast: Volume (m units), AGR (%), 2014-2025
Figure 3.15 Glass Pre-Filled Syringes Market: Drivers and Restraints, 2015-2025
Figure 3.16 Plastic Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 3.17 Plastic Pre-Filled Syringes Market Forecast: Volume (m units), AGR (%), 2014-2025
Figure 3.18 Plastic Pre-Filled Syringes Market: Drivers and Restraints, 2015-2025
Figure 3.19 Pen Injectors and Autoinjectors Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 3.20 Pen Injectors and Autoinjectors Market Forecast: Volume (m units), AGR (%), 2014-2025
Figure 3.21 Pen Injectors and Autoinjectors Market: Drivers and Restraints, 2015-2025
Figure 4.1 World Pre-Filled Syringes Market: Revenues ($m) by National Market, 2014
Figure 4.2 World Pre-Filled Syringes Market: Market Shares (%) by National Market, 2014
Figure 4.3 World Pre-Filled Syringes Market: Market Shares (%) by National Market, 2019
Figure 4.4 World Pre-Filled Syringes Market: Market Shares (%) by National Market, 2025
Figure 4.5 World Pre-Filled Syringes Market: Revenues ($m) by Regional Market, 2014
Figure 4.6 World Pre-Filled Syringes Market: Market Shares (%) by Regional Market, 2014
Figure 4.7 World Pre-Filled Syringes Market: Market Shares (%) by Regional Market, 2019
Figure 4.8 World Pre-Filled Syringes Market: Market Shares (%) by Regional Market, 2025
Figure 4.9 US Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 4.10 Japanese Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 4.11 EU5 Pre-Filled Syringes Market Forecast: Revenues ($m) by National Market, 2014-2025
Figure 4.12 Chinese Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 4.13 Indian Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 4.14 Russian Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 4.15 Brazilian Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 4.16 Mexican Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 5.1 Insulin Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 5.2 Rheumatoid Arthritis Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 5.3 Multiple Sclerosis Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 5.4 Growth Hormones Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 5.5 Heparins Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 5.6 Vaccines Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 5.7 PCSK9 Inhibitors Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 6.1 Sanofi: Lantus Revenue ($m), AGR (%), 2014-2025
Figure 6.2 Novo Nordisk: NovoLog Revenue ($m), AGR (%), 2014-2025
Figure 6.3 Eli Lilly: Humalog Revenue ($m), AGR (%), 2014-2025
Figure 6.4 AbbVie/Eisai: Humira Revenue ($m), AGR (%), 2014-2025
Figure 6.5 Amgen/Pfizer: Enbrel Revenue ($m), AGR (%), 2014-2025
Figure 6.6 Teva: Copaxone Revenue ($m), AGR (%), 2014-2025
Figure 6.7 Biogen Idec: Avonex Revenue ($m), AGR (%), 2014-2025
Figure 6.8 Merck Serono: Rebif Revenue ($m), AGR (%), 2014-2025
Figure 6.9 Novo Nordisk: Norditropin Revenue ($m), AGR (%), 2014-2025
Figure 6.10 Pfizer: Genotropin Revenue ($m), AGR (%), 2014-2025
Figure 6.11 Sanofi: Lovenox Revenue ($m), AGR (%), 2014-2025
Figure 6.12 Pfizer/Eisai: Fragmin Revenue ($m), AGR (%), 2014-2025
Figure 6.13 Aspen/Mylan: Arixtra Revenue ($m), AGR (%), 2014-2025
Figure 7.1 BD: Pharmaceutical Systems Revenue ($m), AGR (%), 2009-2014
Figure 7.2 Gerresheimer: Plastic Systems and Tubular Glass Revenue ($m), AGR (%), 2009-2013
Figure 7.3 Schott: Net Revenue ($m), AGR (%), 2009-2013
Figure 7.4 Weigao: Pre-Filled Syringes Revenue ($m) and Production Volume (m units), 2009-2014
Figure 7.5 Unilife: Net Revenue ($m), AGR (%), 2009-2014
Figure 7.6 Ypsomed: Delivery Devices Revenue ($m), AGR (%), 2009-2014
Figure 7.7 Owen Mumford: Net Revenue ($m), AGR (%), 2009-2014
Figure 7.8 Datwyler: Pharma Packaging Revenue ($m), AGR (%), 2009-2014
Figure 7.9 West Pharmaceutical Services: Packaging Systems and Delivery Systems Revenue ($m), AGR (%), 2009-2014
Figure 8.1 Pre-Filled Syringes Market: Strengths and Weaknesses, 2015-2025
Figure 8.2 Pre-Filled Syringes Market: Opportunities and Threats, 2015-2025
Figure 10.1 World Pre-Filled Syringes Market Forecast: Revenues ($m) by Segment, 2014-2025
Figure 10.2 World Pre-Filled Syringes Market Forecast: Volume (m units) by Segment, 2014-2025

【掲載企業】

AbbVie
Aché Laboratórios Farmacêuticos
Aesica Pharmaceuticals
AI Biosciences
Alchemia
Althea Technologies
Alverix, Inc. (acquired by BD)
Amega Biotech
Amgen
AMRI
Animas Corporation (acquired by Johnson & Johnson)
Antares Pharma
Aptar Pharma
Aptar Stelmi (part of Aptar Pharma)
Asante Solutions
Aspen Pharmacare Holdings
AstraZeneca
Baxter International
Bayer AG
Becton, Dickinson & Company (BD)
Berlin-Chemie
Bespak (subsidiary of Consort Medical)
Biocon
BioConnection
Biodel Inc.
Biogen Idec
Bioject Medical Technologies
Biopartners GmbH
Biosidus
Boehringer Ingelheim
Bristol-Myers Squibb (BMS)
Cambridge Consultants
CareFusion Corporation (acquired by BD)
Carl Zeiss Foundation
Catalent
Cato Software Solutions (acquired by BD)
Celgene Corporation
Cellnovo
Centocor (subsidiary of Johnson & Johnson)
Cipla
Consort Medical
Credence MedSystems
Crossject
D. Medical Industries
Daiichi Sankyo
Daikyo Seiko
Datwyler
Disetronic Group (acquired by Roche)
Dong-A Pharmaceutical Co. Ltd.
Dr. Reddy's Laboratories
Duoject
Eisai
Elcam Medical
Eli Lilly & Company (Lilly)
Express Scripts
Ferring Pharmaceuticals
Future Injection Technologies
Gan & Lee Pharmaceutical
GenCell Biosystems (acquired by BD)
Genentech (subsidiary of Roche)
GeneScience Pharmaceuticals
Gerresheimer
GSK
Hankook Sealtech (acquired by Datwyler)
Haselmeier
Helvoet Pharma (part of Datwyler)
Hikma Pharmaceuticals
Hospira (recently acquired by Pfizer)
Hyaluron Contract Manufacturing (acquired by AMRI)
Incyte Pharmaceuticals
Innoscan (subsidiary of the Stevanato Group)
Insulet Corporation
Jabil Circuit
Janssen Biotech (part of Johnson & Johnson)
Jefferies Group
Johnson & Johnson (J&J)
Keystone Holdings / Columbia Engineered Rubber (acquired by Datwyler)
KIESTRA Lab Automation BV (acquired by BD)
LG Life Sciences
MannKind Corporation
MedImmune (part of AstraZeneca)
Medimop Medical Projects (part of West Pharmaceutical Services)
Medtronic
Merck & Co, (Merck)
Merck Serono (Merck KGaA)
MG Sterile Products (acquired by Nipro)
MGlas (acquired by Nipro)
Mitsubishi Tanabe
Momenta Pharmaceuticals
Mylan
Natco Pharma
Nedis (part of Datwyler)
Nektar Therapeutics
Nemera (formerly Rexam)
Neutral Glass & Allied Industries (acquired by Gerresheimer)
Nipro Corporation
Nipro Medical Corporation (subsidiary of Nipro)
Novartis
Novo Nordisk
Nypro (part of Jabil Circuit)
Ompi (part of the Stevanato Group)
OPKO Health
Optrel (subsidiary of the Stevanato Group)
Oval Medical
Owen Mumford
PA Consulting Group
Palatin Technologies
Pfizer
PharmaJet
Pharmstandard
Phillips-Medsize
Plastef Investissements
Polfa-Tarchomin
Primequal
Regeneron
Revolutions Medical
Rhône Poulenc-Rorer (later subsidiary of Sanofi)
Rigel Pharmaceuticals
Roche
Roehr Products (later acquired by Brunswick Corporation)
Roselabs Bioscience (part of Roselabs Group)
Roselabs Group
ROVI
Safety Syringes (acquired by BD)
Samsung Biologics
Sandoz (division of Novartis)
Sanofi
Schering-Plough (part of Merck)
Schott AG
Schott Kaisha (Schott joint venture)
Schott Xinkang Pharmaceutical Packaging (Schott joint venture)
SciGen Ltd.
Shandong Weigao Group Medical Polymer Company (Weigao)
Shanghai Celgen Bio-Pharmaceutical
Shanghai CP Guojian
SHL Group (Scandinavian Health Ltd)
Sirigen Group Limited (acquired by BD)
SOOIL
Spami (subsidiary of the Stevanato Group)
Specialty Coating Systems
Synthon
Taisei Kako
Takeda Pharmaceutical Company
Tandem Diabetes Care
Terumo Corporation
Teva
The Medical House (acquired by Consort Medical)
The Stevanato Group
tip-top
Tonghua Dongbao
Triveni Polymers (acquired by Gerresheimer)
UCB
Unilife
Valeritas
Vedat Tampas Herméticas (now Gerresheimer Plásticos São Paulo)
Vetter Pharma
Weigao Group Pharmaceutical Packaging Products Company (subsidiary of Weigao)
West Pharmaceutical India Packaging Private (subsidiary of West Pharmaceutical Services)
West Pharmaceutical Services
Wilden Group (now Gerresheimer Regensburg)
Wockhardt
Wyeth (part of Pfizer)
Ypsomed
Zeon Corporation
Zhongding Sealtech (acquired by Datwyler)

【レポートのキーワード】

プレフィルドシリンジ(薬剤充填済み注射器)、ガラス製プレフィルドシリンジ、プラスチック製プレフィルドシリンジ、ペン型注射器、ドラッグデリバリー装置、薬物デリバリー

★調査レポート[プレフィルドシリンジ(薬剤充填済み注射器)の世界市場:ガラス製プレフィルドシリンジ、プラスチック製プレフィルドシリンジ] ( Pre-Filled Syringes Market Forecast 2015-2025 : Prospects for Leading Companies in Plastic Pre-Filled Syringes, Pen Injectors & Autoinjectors, and Glass Pre-Filled Syringes / VGAIN502205) 販売に関する免責事項
[プレフィルドシリンジ(薬剤充填済み注射器)の世界市場:ガラス製プレフィルドシリンジ、プラスチック製プレフィルドシリンジ] ( Pre-Filled Syringes Market Forecast 2015-2025 : Prospects for Leading Companies in Plastic Pre-Filled Syringes, Pen Injectors & Autoinjectors, and Glass Pre-Filled Syringes / VGAIN502205) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆